STAAR Surgical (STAA) 10-Q 4 Nov 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Oct. 02, 2015	Oct. 23, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 2, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Entity Registrant Name	STAAR SURGICAL CO
Entity Central Index Key	718,937
Current Fiscal Year End Date	--01-01
Entity Filer Category	Accelerated Filer
Trading Symbol	STAA
Entity Common Stock, Shares Outstanding		39,888,716

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 02, 2015	Jan. 02, 2015
Current assets:
Cash and cash equivalents	$ 16,081	$ 13,013
Accounts receivable trade, net of allowance for doubtful accounts of $1,921 and $1,589, respectively	12,776	11,054
Inventories, net	14,622	15,717
Prepayments, deposits and other current assets	4,008	4,517
Deferred income taxes	598	596
Total current assets	48,085	44,897
Property, plant and equipment, net	9,944	10,066
Intangible assets, net	719	870
Goodwill	1,786	1,786
Deferred income taxes	759	695
Other assets	617	597
Total assets	61,910	58,911
Current liabilities:
Line of credit	4,168	4,150
Accounts payable	5,790	6,620
Deferred income taxes	301	301
Obligations under capital leases	336	399
Other current liabilities	6,280	4,901
Total current liabilities	16,875	16,371
Obligations under capital leases	224	468
Deferred income taxes	1,866	1,704
Asset retirement obligations	116	115
Pension liability	3,202	3,079
Other long-term liabilities	88	75
Total liabilities	$ 22,371	$ 21,812
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.01 par value; 60,000 shares authorized; 39,883 and 38,429 shares issued and outstanding at October 2, 2015 and January 2, 2015, respectively	$ 399	$ 384
Additional paid-in capital	186,294	178,232
Accumulated other comprehensive loss	(1,017)	(1,070)
Accumulated deficit	(146,137)	(140,447)
Total stockholders’ equity	39,539	37,099
Total liabilities and stockholders’ equity	$ 61,910	$ 58,911

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Oct. 02, 2015	Jan. 02, 2015
Allowance for Doubtful Accounts Receivable, Current	$ 1,921	$ 1,589
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	60,000	60,000
Common stock, shares issued	39,883	38,429
Common stock, shares outstanding	39,883	38,429

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Net sales	$ 18,750	$ 18,188	$ 56,264	$ 58,414
Cost of sales	5,951	6,319	18,206	18,995
Gross profit	12,799	11,869	38,058	39,419
General and administrative	4,853	3,259	14,748	14,064
Marketing and selling	6,284	7,026	17,784	20,189
Research and development	3,684	3,137	10,800	9,118
Other general and administrative expenses	0	0	0	334
Operating loss	(2,022)	(1,553)	(5,274)	(4,286)
Other income (expense):
Interest income	1	7	50	26
Interest expense	(29)	(35)	(97)	(102)
Gain (loss) on foreign currency transactions	20	(628)	(692)	(696)
Other income, net	267	51	437	338
Other income (expense), net	259	(605)	(302)	(434)
Loss before provision for income taxes	(1,763)	(2,158)	(5,576)	(4,720)
Provision (benefit) for income taxes	(11)	548	114	1,134
Net loss	$ (1,752)	$ (2,706)	$ (5,690)	$ (5,854)
Net loss per share - basic and diluted (in dollars per share)	$ (0.04)	$ (0.07)	$ (0.14)	$ (0.15)
Weighted average shares outstanding - basic and diluted (in shares)	39,727	38,369	39,409	38,044

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Net loss	$ (1,752)	$ (2,706)	$ (5,690)	$ (5,854)
Defined benefit pension plans:
Net change in plan assets	(9)	(9)	(27)	(32)
Reclassification into earnings	14	6	44	18
Impact of change in discount rate	0	0	0	(558)
Curtailment gain	0	150	0	687
Foreign currency translation gain (loss)	288	(704)	54	(402)
Tax effect	(99)	231	(18)	124
Other comprehensive income (loss), net of tax	194	(326)	53	(163)
Comprehensive loss	$ (1,558)	$ (3,032)	$ (5,637)	$ (6,017)

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014
Cash flows from operating activities:
Net loss	$ (5,690)	$ (5,854)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	1,563	1,520
Amortization of intangibles	154	317
Deferred income taxes	(148)	161
Change in net pension liability	136	118
Stock-based compensation expense	2,747	4,736
Accretion of asset retirement obligation	0	3
Provision for sales returns and bad debts	331	75
Changes in working capital:
Accounts receivable, net	(2,040)	(1,139)
Inventories, net	1,497	(3,191)
Prepayments, deposits and other current assets	737	207
Accounts payable	(991)	(17)
Other current liabilities	1,387	(1,364)
Net cash used in operating activities	(317)	(4,428)
Cash flows from investing activities:
Acquisition of property, plant and equipment	(1,283)	(2,517)
Cash proceeds from sale of property, plant and equipment	2	68
Net cash used in investing activities	(1,281)	(2,449)
Cash flows from financing activities:
Repayment of capital lease obligations	(306)	(372)
Proceeds from exercise of stock options	2,149	2,793
Proceeds from exercise of warrants	2,800	0
Net cash provided by financing activities	4,643	2,421
Effect of exchange rate changes on cash and cash equivalents	23	(139)
Increase (decrease) in cash and cash equivalents	3,068	(4,595)
Cash and cash equivalents, at beginning of the period	13,013	22,954
Cash and cash equivalents, at end of the period	$ 16,081	$ 18,359

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Oct. 02, 2015
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 1 — Basis of Presentation and Significant Accounting Policies The accompanying interim condensed consolidated financial statements, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition and results of operations. The condensed consolidated results of operations are not necessarily indicative of the results to be expected for any other interim period or for the entire year. Each of the Company's reporting periods ends on the Friday nearest to the quarter ending date and generally consists of 13 weeks. Unless the context indicates otherwise “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries. There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended October 2, 2015, as compared to the recent accounting pronouncements described in our Annual Report on Form 10-K for the fiscal year ended January 2, 2015 and Quarterly Report on Form 10-Q for the fiscal quarter ended July 3, 2015, that are significant to us. During the quarter ended October 2, 2015 the Company reclassified $96,000 from medical device tax to general and administrative expenses in the condensed consolidated statement of operations and $75,000 from other current liabilities to other long-term liabilities in the condensed consolidated balance sheet as of January 2, 2015 and related note disclosures to conform to current period’s presentation.

Inventories

Inventories	9 Months Ended
	Oct. 02, 2015
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	Note 2 — Inventories October 2, January 2, 2015 2015 Raw materials and purchased parts $ 2,539 $ 2,146 Work-in-process 1,879 1,781 Finished goods 13,666 14,504 18,084 18,431 Less: inventory reserves 3,462 2,714 $ 14,622 $ 15,717

Prepayments, Deposits, and Othe

Prepayments, Deposits, and Other Current Assets	9 Months Ended
	Oct. 02, 2015
Prepaid Expenses Deposits and Other Current Assets Disclosure [Abstract]
Prepayments, Deposits, and Other Current Assets Disclosure [Text Block]	October 2, January 2, 2015 2015 Prepayments and deposits $ 2,325 $ 1,991 Income tax receivable 34 1,084 Value added tax (VAT) receivable 747 721 Deferred charges for foreign profits 612 338 Other current assets 290 383 $ 4,008 $ 4,517

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
	Oct. 02, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 4 — Property, Plant and Equipment October 2, January 2, 2015 2015 Machinery and equipment $ 16,714 $ 15,674 Furniture and fixtures 6,840 6,535 Leasehold improvements 8,451 8,400 32,005 30,609 Less: accumulated depreciation 22,061 20,543 $ 9,944 $ 10,066

Intangible Assets

Intangible Assets	9 Months Ended
	Oct. 02, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Note 5 –Intangible Assets October 2, 2015 January 2, 2015 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Net Amount Amortization Net Intangible assets: Patents and licenses $ 9,208 (8,884) $ 324 $ 9,205 $ (8,859) $ 346 Customer relationships 1,307 (1,013) 294 1,302 (911) 391 Developed technology 831 (730) 101 827 (694) 133 Total $ 11,346 $ (10,627) $ 719 $ 11,334 $ (10,464) $ 870

Other Current Liabilities

Other Current Liabilities	9 Months Ended
	Oct. 02, 2015
Other Liabilities Disclosure [Abstract]
Other Liabilities Disclosure [Text Block]	Note 6 – Other Current Liabilities October 2, January 2, Accrued salaries and wages $ 2,208 $ 1,647 Accrued insurance 113 550 Accrued bonuses 1,610 75 Customer credit balances 212 186 Accrued income taxes 148 867 Accrued audit fees 402 352 Accrued commissions 137 309 Other (1) 1,450 915 $ 6,280 $ 4,901 (1) 5

Defined Benefit Pension Plans

Defined Benefit Pension Plans	9 Months Ended
	Oct. 02, 2015
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	Note 7 – Defined Benefit Pension Plans The Company has defined benefit plans covering employees of its Switzerland and Japan operations. Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Service cost $ 107 $ 116 $ 321 $ 349 Interest cost 19 30 57 102 Expected return on plan assets (22) (22) (64) (76) Net amortization of transitional obligation (a) 3 — 8 — Actuarial loss recognized in current period (a) 12 6 37 18 Total $ 119 $ 130 $ 359 $ 393 (a) Amounts reclassified from accumulated other comprehensive income. During the nine months ended October 2, 2015 and October 3, 2014, the Company made cash contributions totaling approximately $ 400,000 558,000

Basic and Diluted Loss Per Shar

Basic and Diluted Loss Per Share	9 Months Ended
	Oct. 02, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note 8 — Basic and Diluted Loss Per Share Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Numerator: Net loss $ (1,752) $ (2,706) $ (5,690) $ (5,854) Denominator: Weighted average common shares and denominator Weighted average common shares outstanding 39,851 38,618 39,533 38,311 Less: Unvested restricted stock (124) (249) (124) (267) Denominator for basic and diluted calculation 39,727 38,369 39,409 38,044 Net loss per share – basic and diluted $ (0.04) $ (0.07) $ (0.14) $ (0.15) Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, Options 2,615 2,198 2,446 2,067 Restricted stock and units 124 312 193 244 Warrants — 460 345 509 Total 2,739 2,970 2,984 2,820

Geographic and Product Data

Geographic and Product Data	9 Months Ended
	Oct. 02, 2015
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Note 9 — Geographic and Product Data The Company markets and sells its products in over 60 5 Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Japan $ 4,249 $ 4,792 $ 12,514 $ 14,349 China 3,095 2,915 8,794 7,675 United States 2,873 2,875 8,464 8,676 Korea 1,690 1,098 5,303 5,671 Spain 1,137 1,178 4,101 4,270 Germany 962 713 2,151 2,625 Other 4,744 4,617 14,937 15,148 Total $ 18,750 $ 18,188 $ 56,264 $ 58,414 100 Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 ICLs $ 12,907 $ 10,640 $ 37,396 $ 35,052 IOLs 4,390 5,763 14,952 18,804 Core products 17,297 16,403 52,348 53,856 Other surgical products 1,453 1,785 3,916 4,558 Total $ 18,750 $ 18,188 $ 56,264 $ 58,414 One customer, a distributor, accounted for 16 14 14 11 16 10 11 The Company sells its products internationally, which subjects the Company to several potential risks, including regional/country economic conditions and regulatory requirements, fluctuating foreign currency exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Oct. 02, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 10 — Stock-Based Compensation The cost that has been charged against income for stock-based compensation is set forth below (in thousands): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Employee stock options $ 625 $ 666 $ 1,818 $ 2,138 Restricted stock 88 141 396 666 Restricted stock units 210 705 484 1,857 Nonemployee stock options —- 41 49 75 Total $ 923 $ 1,553 $ 2,747 $ 4,736 The Company recorded stock-based compensation costs in the following categories on the accompanying condensed consolidated statements of operations (in thousands): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Cost of sales $ 9 $ 32 $ 33 $ 77 General and administrative 543 837 1,667 2,848 Marketing and selling 184 326 539 906 Research and development 187 358 508 905 Total 923 1,553 2,747 4,736 Amounts capitalized as part of inventory 130 131 258 279 Total stock compensation expense $ 1,053 $ 1,684 $ 3,005 $ 5,015 Stock Option Plans The Amended and Restated 2003 Omnibus Equity Incentive Plan (“the Plan”) provides for various forms of stock-based incentives. To date, of the available forms of awards under the Plan, the Company has granted only stock options, restricted stock, unrestricted share grants, restricted stock units, and performance contingent stock units. Options under the plan are granted at fair market value on the date of grant, become exercisable over a three year period, or as determined by the Board of Directors, and expire over periods not exceeding 10 3,579,441 0.95 17.62 123,803 317,858 1,142,202 Assumptions The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model applying the weighted-average assumptions noted in the following table. Expected volatilities are based on historical volatility of the Company’s stock. The expected term of options granted is derived from the historical exercises and post-vesting cancellations and represents the period of time that options granted are expected to be outstanding. The Company has calculated a 7 Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Expected dividend yield 0 % 0 % 0 % 0 % Expected volatility 58 % 56 % 57 % 55 % Risk-free interest rate 1.60 % 1.36 % 1.61 % 1.29 % Expected term (in years) 5.62 4.12 5.61 4.12 Options Shares (000’s) Outstanding at January 2, 2015 3,175 Granted 1,074 Exercised (472) Forfeited or expired (198) Outstanding at October 2, 2015 3,579 Exercisable at October 2, 2015 2,088 On June 1, 2009, the Company issued warrants to Broadwood Partners, L.P. (“Broadwood”), pursuant to a Warrant Agreement granting the right to purchase 700,000 4.00 700,000 2.8 700,000 Restricted Restricted Shares Units (000’s) (000’s) Outstanding at January 2, 2015 247 156 Granted 34 205 Exercised (142) (16) Forfeited (15) (27) Outstanding at October 2, 2015 124 318

Income Taxes

Income Taxes	9 Months Ended
	Oct. 02, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 11 — Income Taxes The provision for income taxes is determined using an estimated annual effective tax rate. The effective tax rate may be subject to fluctuations during the year as new information is obtained, which may affect the assumptions used to estimate the annual effective tax rate, including factors such as the mix of pre-tax earnings in the various tax jurisdictions applicable to the Company, valuation allowances against deferred tax assets, the recognition or de-recognition of tax benefits related to uncertain tax positions, if any, and changes in or the interpretation of tax laws in jurisdictions where the Company conducts business. The Company recorded an income tax benefit of $ 11,000 548,000 114,000 1.1

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 02, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 12 - Commitments and Contingencies Lines of Credit and Guarantee The Company’s wholly owned Japanese subsidiary, STAAR Japan, entered into an agreement on December 28, 2012, as amended, with Mizuho Bank, which provides for borrowings of up to 500,000,000 4.2 1.475 September 30, 2016 500,000,000 4.2 In August 2010, the Company’s wholly-owned Swiss subsidiary, STAAR Surgical AG, entered into a credit agreement with Credit Suisse (“Credit Suisse”). The credit agreement provides for borrowings of up to 1,000,000 1.0 On May 1, 2015, STAAR Surgical AG entered into a guarantee agreement with Bankinter. The agreement, as amended, provides Bankinter with a guarantee of up to EUR 400,000 436,000 564,000 578,000 May 1, 2017 Covenant Compliance The Company is in compliance with the covenants of its credit facilities as of the date of this report. Litigation and Claims From time to time the Company may be subject to various claims and legal proceedings arising out of the normal course of our business. These claims and legal proceedings may relate to, among other things, contractual rights and obligations, employment matters, and claims of product liability. The most significant of these actions, proceedings and investigations are described below. STAAR maintains insurance coverage for product liability and certain securities claims. Legal proceedings can extend for several years, and the matters described below concerning the Company are at very early stages of the legal and administrative process. As a result, these matters have not yet progressed sufficiently through discovery and/or development of important factual information and legal issues to enable the Company to determine whether the proceedings are material to the Company or to estimate a range of possible loss, if any. Unless otherwise disclosed, the Company is unable to estimate the possible loss or range of loss for the legal proceedings described below. While it is not possible to accurately predict or determine outcomes of these items, an adverse determination in one or more of these items currently pending could have a material adverse effect on the Company’s consolidated results of operations, financial position or cash flows. On July 8, 2014, a putative securities class action lawsuit was filed by Edward Todd against STAAR and three officers in the federal court located in Los Angeles, California. In 2015, the Company received a claim from a certain supplier who is also a customer. The supplier is claiming damages related to allegedly defective injectors. The Company is currently investigating the matter and is in discussions with the supplier. The ultimate outcome of this matter cannot be determined with certainty and the Company intends to vigorously protect its interests and work with all parties involved to resolve this matter. The Company has not recorded any loss or accrual in the accompanying condensed consolidated financial statements at October 2, 2015for this matter as the likelihood and amount of loss, if any, has not been determined and is not currently estimable. Employment Agreements The Company’s Chief Executive Officer and certain officers have as provisions of their agreements certain rights, including continuance of cash compensation and benefits, upon a “change in control,” which may include an acquisition of substantially all of its assets, or termination “without cause or for good reason” as defined in the employment agreements. Decommissioning Fund The Company is required by the California Department of Public Health (“CDPH”) to set aside funds for future estimated decommissioning expenses related to certain equipment used in the manufacturing process. The Company has set aside approximately $ 120,000

Basis of Presentation and Sig19

Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 02, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	The consolidated financial statements of the Company present the financial position, results of operations, and cash flows of STAAR Surgical Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities Exchange Commission. In accordance with those rules and regulations certain information and footnote disclosures normally included in comprehensive financial statements have been condensed or omitted pursuant to such rules and regulations. The consolidated balance sheet as of January 2, 2015 was derived from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended January 2, 2015. The accompanying interim condensed consolidated financial statements, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition and results of operations. The condensed consolidated results of operations are not necessarily indicative of the results to be expected for any other interim period or for the entire year. Each of the Company's reporting periods ends on the Friday nearest to the quarter ending date and generally consists of 13 weeks. Unless the context indicates otherwise “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended October 2, 2015, as compared to the recent accounting pronouncements described in our Annual Report on Form 10-K for the fiscal year ended January 2, 2015 and Quarterly Report on Form 10-Q for the fiscal quarter ended July 3, 2015, that are significant to us.
Reclassification, Policy [Policy Text Block]	Prior Year Reclassifications During the quarter ended October 2, 2015 the Company reclassified $96,000 from medical device tax to general and administrative expenses in the condensed consolidated statement of operations and $75,000 from other current liabilities to other long-term liabilities in the condensed consolidated balance sheet as of January 2, 2015 and related note disclosures to conform to current period’s presentation.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Oct. 02, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories, net are stated at the lower of cost, determined on a first-in, first-out basis or market value and consisted of the following (in thousands): October 2, January 2, 2015 2015 Raw materials and purchased parts $ 2,539 $ 2,146 Work-in-process 1,879 1,781 Finished goods 13,666 14,504 18,084 18,431 Less: inventory reserves 3,462 2,714 $ 14,622 $ 15,717

Prepayments, Deposits, and Ot21

Prepayments, Deposits, and Other Current Assets (Tables)	9 Months Ended
	Oct. 02, 2015
Prepaid Expenses and Other Current Assets Disclosure [Abstract]
Schedule Of Prepayments, Deposits, and Other Current Assets Disclosure [Table Text Block]	Prepayments, deposits, and other current assets consisted of the following (in thousands): October 2, January 2, 2015 2015 Prepayments and deposits $ 2,325 $ 1,991 Income tax receivable 34 1,084 Value added tax (VAT) receivable 747 721 Deferred charges for foreign profits 612 338 Other current assets 290 383 $ 4,008 $ 4,517

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
	Oct. 02, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment, net consisted of the following (in thousands): October 2, January 2, 2015 2015 Machinery and equipment $ 16,714 $ 15,674 Furniture and fixtures 6,840 6,535 Leasehold improvements 8,451 8,400 32,005 30,609 Less: accumulated depreciation 22,061 20,543 $ 9,944 $ 10,066

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Oct. 02, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Intangible assets, net consisted of the following (in thousands): October 2, 2015 January 2, 2015 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Net Amount Amortization Net Intangible assets: Patents and licenses $ 9,208 (8,884) $ 324 $ 9,205 $ (8,859) $ 346 Customer relationships 1,307 (1,013) 294 1,302 (911) 391 Developed technology 831 (730) 101 827 (694) 133 Total $ 11,346 $ (10,627) $ 719 $ 11,334 $ (10,464) $ 870

Other Current Liabilities (Tabl

Other Current Liabilities (Tables)	9 Months Ended
	Oct. 02, 2015
Other Liabilities Disclosure [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	October 2, January 2, Accrued salaries and wages $ 2,208 $ 1,647 Accrued insurance 113 550 Accrued bonuses 1,610 75 Customer credit balances 212 186 Accrued income taxes 148 867 Accrued audit fees 402 352 Accrued commissions 137 309 Other (1) 1,450 915 $ 6,280 $ 4,901 (1) 5

Defined Benefit Pension Plans (

Defined Benefit Pension Plans (Tables)	9 Months Ended
	Oct. 02, 2015
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	The following table summarizes the components of net periodic pension cost recorded for the Company’s defined benefit pension plans (in thousands): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Service cost $ 107 $ 116 $ 321 $ 349 Interest cost 19 30 57 102 Expected return on plan assets (22) (22) (64) (76) Net amortization of transitional obligation (a) 3 — 8 — Actuarial loss recognized in current period (a) 12 6 37 18 Total $ 119 $ 130 $ 359 $ 393 (a) Amounts reclassified from accumulated other comprehensive income.

Basic and Diluted Loss Per Sh26

Basic and Diluted Loss Per Share (Tables)	9 Months Ended
	Oct. 02, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table sets forth the computation of basic and diluted net loss per share (in thousands except per share amounts): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Numerator: Net loss $ (1,752) $ (2,706) $ (5,690) $ (5,854) Denominator: Weighted average common shares and denominator Weighted average common shares outstanding 39,851 38,618 39,533 38,311 Less: Unvested restricted stock (124) (249) (124) (267) Denominator for basic and diluted calculation 39,727 38,369 39,409 38,044 Net loss per share – basic and diluted $ (0.04) $ (0.07) $ (0.14) $ (0.15)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	The following table sets forth the weighted average number of options and warrants to purchase shares of common stock and restricted stock, which were not included in the calculation of diluted per share amounts because the effects would be anti-dilutive (in thousands). Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, Options 2,615 2,198 2,446 2,067 Restricted stock and units 124 312 193 244 Warrants — 460 345 509 Total 2,739 2,970 2,984 2,820

Geographic and Product Data (Ta

Geographic and Product Data (Tables)	9 Months Ended
	Oct. 02, 2015
Segment Reporting [Abstract]
Revenue from External Customers by Geographic Areas [Table Text Block]	The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Japan $ 4,249 $ 4,792 $ 12,514 $ 14,349 China 3,095 2,915 8,794 7,675 United States 2,873 2,875 8,464 8,676 Korea 1,690 1,098 5,303 5,671 Spain 1,137 1,178 4,101 4,270 Germany 962 713 2,151 2,625 Other 4,744 4,617 14,937 15,148 Total $ 18,750 $ 18,188 $ 56,264 $ 58,414
Revenue from External Customers by Products and Services [Table Text Block]	The composition of the Company’s net sales by product line is as follows (in thousands): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 ICLs $ 12,907 $ 10,640 $ 37,396 $ 35,052 IOLs 4,390 5,763 14,952 18,804 Core products 17,297 16,403 52,348 53,856 Other surgical products 1,453 1,785 3,916 4,558 Total $ 18,750 $ 18,188 $ 56,264 $ 58,414

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 02, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule Of Compensation Cost [Table Text Block]	The cost that has been charged against income for stock-based compensation is set forth below (in thousands): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Employee stock options $ 625 $ 666 $ 1,818 $ 2,138 Restricted stock 88 141 396 666 Restricted stock units 210 705 484 1,857 Nonemployee stock options —- 41 49 75 Total $ 923 $ 1,553 $ 2,747 $ 4,736
Schedule of Share-based Compensation, Activity [Table Text Block]	The Company recorded stock-based compensation costs in the following categories on the accompanying condensed consolidated statements of operations (in thousands): Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Cost of sales $ 9 $ 32 $ 33 $ 77 General and administrative 543 837 1,667 2,848 Marketing and selling 184 326 539 906 Research and development 187 358 508 905 Total 923 1,553 2,747 4,736 Amounts capitalized as part of inventory 130 131 258 279 Total stock compensation expense $ 1,053 $ 1,684 $ 3,005 $ 5,015
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant. Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Expected dividend yield 0 % 0 % 0 % 0 % Expected volatility 58 % 56 % 57 % 55 % Risk-free interest rate 1.60 % 1.36 % 1.61 % 1.29 % Expected term (in years) 5.62 4.12 5.61 4.12
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of option activity under the Plan for the nine-month period ended October 2, 2015 is presented below: Options Shares (000’s) Outstanding at January 2, 2015 3,175 Granted 1,074 Exercised (472) Forfeited or expired (198) Outstanding at October 2, 2015 3,579 Exercisable at October 2, 2015 2,088
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	A summary of restricted stock and restricted stock unit’s activity under the Plan for the nine-month period ended October 2, 2015 is presented below: Restricted Restricted Shares Units (000’s) (000’s) Outstanding at January 2, 2015 247 156 Granted 34 205 Exercised (142) (16) Forfeited (15) (27) Outstanding at October 2, 2015 124 318

Basis of Presentation and Sig29

Basis of Presentation and Significant Accounting Policies (Details Textual)	3 Months Ended
	Oct. 02, 2015USD ($)
Other Noncurrent Liabilities [Member]
Prior Period Reclassification Adjustment	$ 75,000
General and Administrative Expense [Member]
Prior Period Reclassification Adjustment	$ 96,000

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Oct. 02, 2015	Jan. 02, 2015
Public Utilities, Inventory [Line Items]
Raw materials and purchased parts	$ 2,539	$ 2,146
Work-in-process	1,879	1,781
Finished goods	13,666	14,504
Inventory, Gross	18,084	18,431
Less: inventory reserves	3,462	2,714
Inventory, Net	$ 14,622	$ 15,717

Prepayments, Deposits, and Ot31

Prepayments, Deposits, and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 02, 2015	Jan. 02, 2015
Prepayments, Deposits, and Other Current Assets [Line Items]
Prepayments and deposits	$ 2,325	$ 1,991
Income tax receivable	34	1,084
Value added tax (VAT) receivable	747	721
Deferred charges for foreign profits	612	338
Other current assets	290	383
Prepayments, Deposits, and Other Current Assets	$ 4,008	$ 4,517

Property, Plant and Equipment32

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Oct. 02, 2015	Jan. 02, 2015
Property, Plant and Equipment [Line Items]
Machinery and equipment	$ 16,714	$ 15,674
Furniture and fixtures	6,840	6,535
Leasehold improvements	8,451	8,400
Property, Plant and Equipment, Gross	32,005	30,609
Less: accumulated depreciation	22,061	20,543
Property, Plant and Equipment, Net	$ 9,944	$ 10,066

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 02, 2015	Jan. 02, 2015
Intangible assets:
Long-lived intangible assets, Gross Carrying Amount	$ 11,346	$ 11,334
Long-lived intangible assets, Accumulated Amortization	(10,627)	(10,464)
Long-lived intangible assets, Net	719	870
Patents and Licenses [Member]
Intangible assets:
Long-lived intangible assets, Gross Carrying Amount	9,208	9,205
Long-lived intangible assets, Accumulated Amortization	(8,884)	(8,859)
Long-lived intangible assets, Net	324	346
Customer relationships [Member]
Intangible assets:
Long-lived intangible assets, Gross Carrying Amount	1,307	1,302
Long-lived intangible assets, Accumulated Amortization	(1,013)	(911)
Long-lived intangible assets, Net	294	391
Developed technology [Member]
Intangible assets:
Long-lived intangible assets, Gross Carrying Amount	831	827
Long-lived intangible assets, Accumulated Amortization	(730)	(694)
Long-lived intangible assets, Net	$ 101	$ 133

Other Current Liabilities (Deta

Other Current Liabilities (Details) - USD ($) $ in Thousands		Oct. 02, 2015	Jan. 02, 2015
Other Liabilities, Current [Line Items]
Accrued salaries and wages		$ 2,208	$ 1,647
Accrued insurance		113	550
Accrued bonuses		1,610	75
Customer credit balances		212	186
Accrued income taxes		148	867
Accrued audit fees		402	352
Accrued commissions		137	309
Other	[1]	1,450	915
Other Liabilities, Current		$ 6,280	$ 4,901
[1]	No individual item in “Other” above exceeds 5% of the total other current liabilities

Other Current Liabilities (De35

Other Current Liabilities (Details Textual)	9 Months Ended
	Oct. 02, 2015
Other Liabilities, Current [Line Items]
Percentage Of Other Current Liabilities	5.00%

Defined Benefit Pension Plans36

Defined Benefit Pension Plans (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost		$ 107	$ 116	$ 321	$ 349
Interest cost		19	30	57	102
Expected return on plan assets		(22)	(22)	(64)	(76)
Net amortization of transitional obligation	[1]	3	0	8	0
Actuarial loss recognized in current period	[1]	12	6	37	18
Total		$ 119	$ 130	$ 359	$ 393
[1]	Amounts reclassified from accumulated other comprehensive income.

Defined Benefit Pension Plans37

Defined Benefit Pension Plans (Details Textual) - USD ($)	9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014
Swiss Pension Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Contributions By Employer	$ 400,000	$ 558,000

Basic and Diluted Loss Per Sh38

Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Numerator:
Net loss	$ (1,752)	$ (2,706)	$ (5,690)	$ (5,854)
Weighted average common shares and denominator for basic and diluted calculation:
Weighted average common shares outstanding	39,851	38,618	39,533	38,311
Less: Unvested restricted stock	(124)	(249)	(124)	(267)
Denominator for basic and diluted calculation	39,727	38,369	39,409	38,044
Weighted average effects of potentially dilutive common stock:
Net loss per share - basic and diluted (in dollars per share)	$ (0.04)	$ (0.07)	$ (0.14)	$ (0.15)

Basic and Diluted Loss Per Sh39

Basic and Diluted Loss Per Share (Details 1) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,739	2,970	2,984	2,820
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,615	2,198	2,446	2,067
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	124	312	193	244
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	460	345	509

Geographic and Product Data (De

Geographic and Product Data (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Geographic And Sales [Line Items]
Net sales	$ 18,750	$ 18,188	$ 56,264	$ 58,414
Japan [Member]
Geographic And Sales [Line Items]
Net sales	4,249	4,792	12,514	14,349
China [Member]
Geographic And Sales [Line Items]
Net sales	3,095	2,915	8,794	7,675
United States [Member]
Geographic And Sales [Line Items]
Net sales	2,873	2,875	8,464	8,676
Korea [Member]
Geographic And Sales [Line Items]
Net sales	1,690	1,098	5,303	5,671
Spain [Member]
Geographic And Sales [Line Items]
Net sales	1,137	1,178	4,101	4,270
Germany [Member]
Geographic And Sales [Line Items]
Net sales	962	713	2,151	2,625
Other [Member]
Geographic And Sales [Line Items]
Net sales	$ 4,744	$ 4,617	$ 14,937	$ 15,148

Geographic and Product Data (41

Geographic and Product Data (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Product Information [Line Items]
Net sales	$ 18,750	$ 18,188	$ 56,264	$ 58,414
Other Countries [Member]
Product Information [Line Items]
Net sales	4,744	4,617	14,937	15,148
ICLs [Member]
Product Information [Line Items]
Net sales	12,907	10,640	37,396	35,052
IOLs [Member]
Product Information [Line Items]
Net sales	4,390	5,763	14,952	18,804
Core products [Member]
Product Information [Line Items]
Net sales	17,297	16,403	52,348	53,856
Other surgical products [Member]
Product Information [Line Items]
Net sales	$ 1,453	$ 1,785	$ 3,916	$ 4,558

Geographic and Product Data (42

Geographic and Product Data (Details Textual)	Jan. 02, 2015	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Geographic and Product Data [Line Items]
Number of Countries in which Entity Operates		60		60
Sales Exceed Percentage				5.00%
One Operating Segment [Member]
Geographic and Product Data [Line Items]
Segment Sales To Consolidated Sales Percentage		100.00%		100.00%
Accounts Receivable [Member]
Geographic and Product Data [Line Items]
Concentration Risk, Percentage	11.00%
Distributor [Member] | Sales Revenue, Net [Member]
Geographic and Product Data [Line Items]
Concentration Risk, Percentage		14.00%	11.00%	14.00%	11.00%
Customer One [Member] | Accounts Receivable [Member]
Geographic and Product Data [Line Items]
Concentration Risk, Percentage	10.00%			16.00%
Customer One [Member] | Sales Revenue, Net [Member]
Geographic and Product Data [Line Items]
Concentration Risk, Percentage		16.00%	14.00%	16.00%	14.00%

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	$ 923	$ 1,553	$ 2,747	$ 4,736
Employee stock options [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	625	666	1,818	2,138
Restricted stock [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	88	141	396	666
Restricted stock units [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	210	705	484	1,857
Nonemployee stock options [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	$ 0	$ 41	$ 49	$ 75

Stock-Based Compensation (Det44

Stock-Based Compensation (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Schedule of Employee Service Share-based Compensation [Line Items]
Total stock compensation expense	$ 1,053	$ 1,684	$ 3,005	$ 5,015
Amounts capitalized as part of inventory	130	131	258	279
Total	923	1,553	2,747	4,736
Cost of Sales [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Total stock compensation expense	9	32	33	77
General and administrative [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Total stock compensation expense	543	837	1,667	2,848
Marketing and selling [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Total stock compensation expense	184	326	539	906
Research and development [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Total stock compensation expense	$ 187	$ 358	$ 508	$ 905

Stock-Based Compensation (Det45

Stock-Based Compensation (Details 2)	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Schedule of Employee Service Share-based Compensation [Line Items]
Expected dividend yield	0.00%	0.00%	0.00%	0.00%
Expected volatility	58.00%	56.00%	57.00%	55.00%
Risk-free interest rate	1.60%	1.36%	1.61%	1.29%
Expected term (in years)	5 years 7 months 13 days	4 years 1 month 13 days	5 years 7 months 10 days	4 years 1 month 13 days

Stock-Based Compensation (Det46

Stock-Based Compensation (Details 3) shares in Thousands	9 Months Ended
	Oct. 02, 2015shares
Schedule of Employee Service Share-based Compensation [Line Items]
Options,Outstanding at January 2, 2015	3,175
Options, Granted, Shares	1,074
Options, Exercised, Shares	(472)
Options, Forfeited or expired, Shares	(198)
Options,Outstanding at October 2, 2015	3,579
Options,Exercisable at October 2, 2015	2,088

Stock-Based Compensation (Det47

Stock-Based Compensation (Details 4) shares in Thousands	9 Months Ended
	Oct. 02, 2015shares
Restricted Stock [Member]
Outstanding at January 2, 2015	247
Granted	34
Exercised	(142)
Forfeited	(15)
Outstanding at October 2, 2015	124
Restricted Stock Units (RSUs) [Member]
Outstanding at January 2, 2015	156
Granted	205
Exercised	(16)
Forfeited	(27)
Outstanding at October 2, 2015	318

Stock-Based Compensation (Det48

Stock-Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended		9 Months Ended
	Jul. 27, 2015	May. 27, 2015	Oct. 02, 2015	Jan. 02, 2015	Jun. 01, 2009
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding			3,579,000	3,175,000
Estimated Forfeiture Rate			7.00%
Broadwood [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Warrants And Rights Exercisable		700,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					700,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 4
Warrants Issued Value		$ 2.8
Stock Issued During Period, Shares, New Issues	700,000
Restricted Stock [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested			124,000	247,000
Restricted Stock [Member] | Maximum [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			4 years
Restricted Stock [Member] | Minimum [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			1 year
Restricted Stock Units (RSUs) [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested			318,000	156,000
2003 Omnibus Plan [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding			3,579,441
Lower Range of Exercise Prices			$ 0.95
Upper Range of Exercise Prices			$ 17.62
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			10 years
2003 Omnibus Plan [Member] | Restricted Stock [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested			123,803
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			1,142,202
2003 Omnibus Plan [Member] | Restricted Stock Units (RSUs) [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested			317,858

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2015	Oct. 03, 2014	Oct. 02, 2015	Oct. 03, 2014
Income Taxes [Line Items]
Income Tax Expense (Benefit)	$ (11)	$ 548	$ 114	$ 1,134

Commitments and Contingencies (

Commitments and Contingencies (Details Textual)	9 Months Ended
	Oct. 02, 2015USD ($)	Oct. 02, 2015JPY (¥)	May. 01, 2015CHF (SFr)	May. 01, 2015EUR (€)	Jan. 02, 2015USD ($)	Jan. 02, 2015JPY (¥)	Dec. 28, 2012JPY (¥)	Aug. 31, 2010CHF (SFr)
Loss Contingencies [Line Items]
Line Of Credit, Current	$ 4,168,000				$ 4,150,000
Line of Credit Facility, Expiration Date	Sep. 30, 2016
Bankinter [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 436,000			€ 400,000
Line of Credit Facility, Current Borrowing Capacity	$ 578,000		SFr 564,000
Debt Instrument, Maturity Date	May 1, 2017
CDPH [Member] | Other Noncurrent Assets [Member]
Loss Contingencies [Line Items]
Restricted Cash and Cash Equivalents, Noncurrent	$ 120,000				120,000
Mizuho Bank [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	4,200,000						¥ 500,000,000
Line Of Credit, Current	$ 4,200,000	¥ 500,000,000			$ 4,200,000	¥ 500,000,000
Mizuho Bank [Member] | Prime Rate [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Interest Rate at Period End	1.475%	1.475%
Credit Suisse [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity | SFr								SFr 1,000,000
Line Of Credit, Current	$ 1,000,000